ADVERTISEMENT
ADVERTISEMENT
blind mole rat
Blind Mole Rats Use Junk DNA to Combat Cancer
Activation of retrotransposons in the animals’ cancerous cells sets off an innate immune response that triggers cell death.
Blind Mole Rats Use Junk DNA to Combat Cancer
Blind Mole Rats Use Junk DNA to Combat Cancer

Activation of retrotransposons in the animals’ cancerous cells sets off an innate immune response that triggers cell death.

Activation of retrotransposons in the animals’ cancerous cells sets off an innate immune response that triggers cell death.

cancer therapetics
Emil Freireich, cancer, leukemia, platelets, blood, chemotherapy, University of Texas MD Anderson Cancer Center
Pioneering Cancer Researcher Emil Freireich Dies at 93
Asher Jones | Feb 5, 2021 | 3 min read
The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
The Scientist’s Creative Services Team | Jan 20, 2021 | 1 min read
Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.
Hadiyah-Nicole Green Targets Cancer With Lasers
Emily Makowski | Apr 1, 2020 | 3 min read
Spurred by family tragedy, the medical physicist wants to treat cancer in a new way.
Philip Leder, Who Deciphered Amino Acid Sequences, Dies
Ashley Yeager | Feb 12, 2020 | 4 min read
The Harvard Medical School researcher’s work on the genetic basis of protein coding and production led him to make groundbreaking discoveries in immunology, molecular biology, and cancer genetics.
cryopreservation facility
Immune Cell Bank Bets on Future CAR T Success
Nicoletta Lanese | Aug 16, 2019 | 6 min read
The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.
Genetically Personalized Fruit Flies Screen for Cancer Drugs
Ruth Williams | May 22, 2019 | 4 min read
Fly avatars bearing multiple genetic changes akin to those of a cancer patient lead to a tailor-made treatment that has shrunk the patient’s tumors.
Infographic: Inside Melanoma Invasion
Catherine Offord | Mar 31, 2017 | 1 min read
See what cytokine activity and cellular starvation have to do with cancer metastasis.
Turning Tumor Cells Against Cancer
Anna Azvolinsky | Feb 8, 2016 | 3 min read
In mice, cancer cells genetically modified to express an anticancer cytokine home to tumors and can reduce their growth. 
Radiation-Fighting Drug
Rina Shaikh-Lesko | May 16, 2014 | 1 min read
A hydroxylase inhibitor that prolongs the action of a gut-protective protein shows promise in mice as a treatment for radiation poisoning.
Nano-vehicles for Cancer Drugs
James Netterwald | May 20, 2013 | 5 min read
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
AACR Talk
The Scientist Staff | Apr 11, 2013 | 3 min read
Some notable quotes from this week’s meeting on cancer research
Chicken Virus Attacks Cancer Cells
Bob Grant | Apr 9, 2013 | 1 min read
Researchers have genetically engineered a virus that is deadly to chickens and found that it can kill prostate cancer in vitro.
Q&A: The Cancer Tradeoff
Chris Palmer | Apr 3, 2013 | 3 min read
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Models of Transparency
Joan K. Heath, Richard White, Kirsten C. Sadler, and David Langenau | Apr 1, 2013 | 10+ min read
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Funding Mishaps Rattle Review Panel
Dan Cossins | Oct 15, 2012 | 2 min read
Every member of the scientific review panel at Texas’s $3-billion cancer research funding agency has quit, citing concerns about a lack of proper peer review.
Cancer-Fighting Virus
Ruth Williams | Jun 13, 2012 | 3 min read
A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.
Delivering Silence
Sabrina Richards | Mar 1, 2012 | 2 min read
Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.
ADVERTISEMENT